Terpenoid Therapeutics Obtains $1,500,000 Series A Financing Round

  • Feed Type
  • Date
    1/25/2010
  • Company Name
    Terpenoid Therapeutics
  • Mailing Address
    2500 Crosspark Road Coralville, IA 42241
  • Company Description
    Terpenoid Therapeutics, Inc. is a drug discovery and development company focused on cancer. We use the platform of terpene chemistry to develop candidate drug molecules. Our team is creating, testing, and developing novel drug candidates using cutting-edge technologies. We seek to generate a robust pipeline of terpene-derived therapeutic agents.
  • Website
    http://www.terpenoidtherapeutics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $1,500,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    These private investments allow the company essential flexibility to explore new facets of our lead compounds quickly. The grants also provide important validation of the Terpenoid goals by external scientific panels. To date, Terpenoid has received a total of four of these highly competitive NIH awards and has several other proposals currently under review.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy